TECH BUYER Feb 2021 - IDC Perspective - Doc # US46583321

U.S. Life Science Top 10 Market Trends for 2021

By: Nimita LimayeResearch Vice President, Michael TownsendResearch Director, Life Sciences Commercial Strategies

Table of Contents

Executive Snapshot

Figure: Executive Snapshot: U.S. Life Science Top 10 Market Trends for 2021

Situation Overview

In This Study

Future Outlook

Market Trend 1: Exponential Growth in Decentralized Clinical Trials, Remote Monitoring of Sites, and Remote Patient Engagement Technologies

Market Trend 2: An Increased Focus on Risk-Based Quality Management (RBQM) and Predictive Analytics in a Time of Turbulence

Market Trend 3: Transitioning from a Closed-Door Policy Toward a World of Data Transparency and Collaboration

Market Trend 4: Accelerated Growth of Software as a Medical Device as a Result of COVID-19, Prescription Digital Therapeutics Gain Increasing Attention

Market Trend 5: Blurring the Borders — Hybrid Trials, SCAs, and the Increasing Use of RWE

Market Trend 6: The COVID-19 Pandemic Exposed Challenges — and Opportunities — for Innovation in Life Science Supply Chains

Market Trend 7: Real-World Evidence to Become a Factor in Drug and Device Pricing, Not Just Approvals

Market Trend 8: Life Science Companies Accelerating Deployment of Critical Applications in the Cloud — Just in Time for COVID-19

Market Trend 9: Digital Technology Transfer to Accelerate Time to Market for Vaccines and Other Biologics

Market Trend 10: Remote Engagement with Prescribers Took Off in the Pandemic But Will Remain a Powerful Tool for Life Science Commercial Teams

Advice for the Technology Buyer

Learn More

Related Research

Synopsis

Content


Related Links